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1. Introduction
Soft nanostructures are particularly important 
because they can be attuned to various 
environmental responses.1,2 Biomolecular 
building blocks including peptides, lipids, 
nucleosides and others are interesting candidates 
which can be self-assembled under appropriate 
conditions to form different nanoscale 
structures.1–5 Self-assembling peptides are one 
of the most attractive and useful building blocks 
in making various nanostructures including 
nanotubes, nanorods, nanovesicles, nanobelts, 
nanofibers and others due to their chemical 
diversity, biocompatibility, biodegradability and 
foldability into specific structures depending 
on the sequence and environmental responses. 
These peptide based building blocks can be 
self-assembled in water using various non-
covalent interactions including hydrogen 
bonds, π-π stacking interactions, electrostatic 
interactions and hydrophobic interactions to 
form a specific type of nanostructure depending 
on suitable conditions. Stimuli-responsive 
nanostructures are of particular importance as 
these nanostructured biomaterials can be used 
as stimuli-responsive nanocarriers for delivering 
drugs and other important biological molecules 
to the target sites. For example, nanovesicles can 
be envisaged as nanocarriers for carrying drugs 
and other important biomolecules in response to 
environmental systems like pH, temperature and 
others.6 Environmental response is very important 
in controling the self-assembly pattern of a specific 
building block and dictating the formation of a 
particular type of nanostructure under specific 
conditions. This is because pH, concentration of 
the peptide, and salt concentration can play an 
important role in nanostructural transformation. 
The self-assembling short peptide-based 
nanoporous materials can be considered a new 
class of nanoporous materials as they not only 
differ from the existing type of nanoporous 
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materials like zeolites, metal organic framework 
(MOF) and others, but are also found to be 
biodegradable and eco-friendly materials.7 We 
will focus, in this review, on self-assembling, 
water soluble short peptide(with two to seven 
residues) based various nanostructure formations, 
nanostructural transformations, short peptide-
based nanoporous materials, short peptide-
based nanofibrous hydrogels with their various 
applications, nanovesicles such as drug delivery 
vehicles and amyloid-like fibril formations.
2. Short Peptide-Based Nanobiomaterials
Various nanostructures including nanotubes, 
nanovesicles, nanorods, nanofibrills, nanobelts and 
others have been obtained from self-assembling 
short peptide-based building blocks. Among these 
nanostructures, peptide-based nanotubes and 
nanofibrils are very common and can offer various 
applications in biology.
3. Tubular Peptide Nanostructures
Cyclic peptide-based nanostructures can be 
regarded as the first engineered structures. 
Ghadiri and his coworkers have made a pioneering 
contribution in the construction of cyclic peptide-
based nanotubes.8–10 They conceptualized the 
self-assembly of alternating D- and L-α-amino 
acid-based cyclic peptides through intermolecular 
hydrogen bonding to form nanotubular structures 
with a desired diameter. The diameter of the 
nanotube can be varied depending on the ring 
size of the cyclic peptide building blocks. Different 
amino acid residues including unnatural amino 
acid residues can be incorporated into the cyclic 
peptide building blocks as the side chain of the 
amino acid residue can be manipulated. Granja 
and his co-workers have used a different self-
assembling building block based on a hybrid 
of α-γ-cyclic peptides in making peptide 
nanotubes.11,12 These nanotubes have various 
applications as antibacterial agents, artificial 
photosystems, biosensors, catalysts and others.13–19 
There is a recent review regarding cyclic peptide 
nanotubes by Granja and his co-workers.20
Relatively less attention has been paid to 
linear peptide-based nanotubes. Görbitz and his 
co-workers made a seminal contribution in the field 
of short peptide-based nanotubes. Linear water-
soluble hydrophobic dipeptides (L-Leu-L-Leu, 
L-Leu-L-Phe, L-Phe-L-Leu, and L-Ile-L-Leu) can 
be self-assembled utilizing head to-tail (NH
3
+ ⋅ ⋅ ⋅ 
−OOC) hydrogen bonds to form nanotubular 
structures.21–25 These nanotubular structures 
contain water molecules inside the core channel.21–25 
Another example of water-filled nanotubes is a 
dipeptide (tryptophylglycine) and these nanotubes 
show negative thermal expansion.26,27
The self-association of the Phe-Phe dipeptide 
is really interesting as this sequence is the core 
recognition element found in the β-amyloid 
polypeptide.28 Nanotubes are formed from the 
self-assembly of this dipeptide in water29 and also 
in crystals.30 These nanotubes are thermally and 
chemically stable.31 Vapour deposition methods 
at 200° C using a vacuum chamber have been 
used by Gazit and his coworkers to prepare self-
assembled large arrays of short aromatic peptide-
based nanotubes.32 They have also demonstrated 
that arrays of aromatic dipeptide-based nanotubes 
can find potential applications in developing high-
surface-area electrodes for storing energies and 
making microfluidic chips.32
Chauhan and his coworkers have investigated 
the self-assembly process of a dipeptide containing 
a noncoded, achiral, α,β-dehydrophenylalanine 
residue (∆Phe).33 Introducing the ∆Phe residue in 
the peptide sequence makes it conformationally 
rigid, and also enables the peptide to resist 
proteolytic degradation. Interestingly,  the dipeptide 
(Phe–∆Phe) has been self-assembled into a 
distinct nanotubular structure. The thermostable, 
enzymatically stable and pH stable nature of 
this nanotube makes it useful for applications in 
biological systems and also in material science.
Zhang and his coworkers have contributed 
significantly in making peptide surfactant based 
nanotubes.34–36 These peptide surfactants are 
composed of a hydrophilic head with one or two 
charged amino acid residues and a hydrophobic tail 
of four or more consecutive hydrophobic residues. 
Upon self-assembly in water, these peptides form 
open-ended nanotubes with diameters ranging 
from 30–50 nm.
Each of the two dipeptides (H
3
 N+-β-Ala(1)-
Ala(2)-COO− Peptide 1; H
3
 N+-δ-Ava(1)-Phe(2)-
COO− Peptide 2) containing an N-terminally 
positioned ω-amino acid residue (β-alanine/ 
δ-amino valeric acid) self-associates to form 
nanotubes in the solid state as well as in an aqueous 
solution.37 Though they form hollow nanotubular 
structures both in the solid state and in a solution, 
their self-assembling nature in these two states is 
different. This causes a difference in the internal 
diameters of these nanotubes in a solution and 
in a solid state structure. These nanotubes are 
stable proteolytically, thermally, and over a wide 
range of pH values (1−13).37 In the crystal state, 
both peptides adopt an extended backbone 
conformation. A vital role has been played by 
water molecules in the formation and stabilization 
of nanotubular structures through intermolecular 
Hydrogel: Hydrogel is an 
important type of soft 
material in which numerous 
water molecules are getting 
trapped within the network 
structure given by the gelator 
molecules under appropriate 
conditions.
Amyloid: Amyloids are 
fibrous protein aggregates, 
insoluble in nature and they 
share specific structural 
features. Unusual deposition 
of amyloid in organs leads 
to amyloidosis and can 
play a key role in many 
neurodegenerative disorders.
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hydrogen bonding along the crystallographic 
b axis (Figure 1).37 Head to tail NH
3
+ ⋅ ⋅ ⋅ −OOC, 
NH
3
+ ⋅ ⋅ ⋅ O(W), H(W)⋅ ⋅ ⋅−OOC, NH
3
+ ⋅ ⋅ ⋅O = C 
(amide), and amide NH⋅ ⋅ ⋅ −OOC intermolecular 
hydrogen bonds have been observed in the case 
of peptide 1, in the formation of nanotubular 
architecture. Head to tail NH
3
+  ⋅ ⋅ ⋅ −OOC, NH
3
+  ⋅ ⋅ ⋅ 
O(W), H(W) ⋅ ⋅ ⋅ −OOC, H(W)⋅ ⋅ ⋅O = C (amide), 
and amide NH ⋅ ⋅ ⋅ O = C (amide) intermolecular 
hydrogen bonds have been observed in the 
formation of nanotubular architecture in the 
solid state in the case of peptide 2.37 Aromatic π-π 
stacking interactions with an average π-π distance 
of 4.9 Å are also responsible for the stabilization 
of nanotubular structures for peptide 2. The 
temperature-dependent X-ray powder diffraction 
(XRPD) data clearly show that nanotubular 
structures are stable upto 70° C as the diffraction 
intensity and pattern remain unaltered for peptides 
1 and 2 upto this temperature.37 The TEM images 
of these two dipeptides reveal a uniform and well-
ordered hollow nanotubular structures with a total 
diameter of 27 nm and an inner diameter of 5 nm 
for the peptide 1 nanotube, and a total diameter of 
44 nm with a 15 nm inner diameter for the peptide 
2 nanotube.37 These peptide nanotubes are stable 
towards proteolytic degradation for more than 
24 hrs as they are composed of N-terminally located 
proteolytically stable non-protein ω-amino acid 
residues in the peptide backbone. Solution state 
FTIR data and the crystal structure support the 
formation of intermolecularly hydrogen-bonded 
self-assembled β-sheet conformations for both 
peptides in solution and crystals. The folding of 
the extended β-sheet conformation along one axis 
of the 2D layered structure utilizing intermolecular 
hydrogen bonds and/or π-π interactions leads to the 
formation of a tubular structure in nanoscale.37 
Three water-soluble short peptides each 
having a common motif, a hybrid of β,α-amino 
acid residues (β-Ala-L-Xaa, Xaa = Val/Ile/Phe) are 
self-assembled to form hollow nanotubes.38 These 
nanotubes are stable towards heat up to 80° C, a 
wide range of pH (2–10), and against proteolytic 
degradation.38 These dipeptide-based robust 
crystalline nanotubes have been used as suitable 
templates for fabricating dipeptide-stabilized gold 
nanoparticles on their outer surfaces.
4. Peptide Nanofibers
Peptide-based nanofibers as biomaterials have been 
extensively covered and reviewed elsewhere by 
different research groups.39–41 We have, therefore, 
concisely discussed self-assembling short peptide-
based nanofibers in this review. These nanofibers 
are very common and are biologically important 
materials with different applications.2,42
5. Amyloid Fibers
Amyloid fibrils are thought to be associated with 
a large number of fatal human diseases including 
Alzheimer’s, Parkinson’s, Type II diabetes and 
others.43,44 Currently, there are about 20 human 
diseases which are linked to the formation of 
amyloid fibrils having diameters of 7–10 nm. 
These fibrils exhibit well-ordered structures. 
This indicates that they form a typical β-sheet 
conformation on self-association. Moreover, these 
fibers show a typical green- gold birefringence 
under polarized light after being stained with a 
water-soluble dye Congo Red. These fibers interact 
with another physiological dye Thioflavin T, and 
after binding with this dye these fibrils exhibit an 
emission at 482 nm. Amyloid fibrils are generally 
formed by polypeptides containing 30–40 amino 
acid residues. In this review, amyloid fibrils formed 
by self-assembling oligopeptides with less than 
eight amino acid residues will be discussed.
Kapurniotu and his coworkers have reported 
that a hexapeptide fragment of human IAPP 
forms a β-sheet forming typical amyloid fibrils 
upon self-assembly.45 This hexapeptide exhibits 
structural and biophysical properties similar to 
that of a full-length 37 amino acid polypeptide. 
They have also shown that the short peptide and 
the full-length IAPP assemblies have the same 
cytotoxic activity towards the pancreatic cell line 
RIN5fm.45 Serranno and his co-workers studied 
a series of de novo designed hexapeptides which 
Figure 1(a, b): Construction of water-mediated nanotubular structures using 
hydrogen-bonds obtained from self-assembling dipeptides 1 and 2 in crystals.37
?? ??
?????
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form amyloid fibrils upon self-aggregation 
in water. They have also shown the residue-
specific propensity of amyloid fibril formation 
in a series of model hexapeptides.46 Gazit and 
his co-workers have systematically investigated 
several tetrapeptide and pentapeptide fragments 
of the human calcitonin hormone, which forms 
amyloid fibrils.47,48 They have also established the 
fact that aromatic-aromatic interactions play a 
vital role in amyloid fibril formation using model 
oligopeptides.49 Johansson and his coworkers 
have shown that charged attractions and the 
β-sheet forming tendency are important criteria 
for the formation of amyloid fibrils from model 
tetrapeptides.50
Our group is also involved in studying 
synthetic self-assembling water-soluble tripeptides 
which form intermolecularly hydrogen-bonded 
supramolecular β-sheet structures and amyloid 
fibrils. A tripeptide Val–Ile–Ala, which has a 
sequence identity with the C-terminal section of the 
Alzheimer’s Aβ-peptide (Aβ 40–42), self-associates 
in crystals to form first a β-sheet structure, which, 
upon further self-assembly, gives rise to straight, 
unbranched nanofibrils showing amyloid-like 
behavior.51 It is important to mention that the 
tripeptide Ala–Val–Ile has a different amino acid 
sequence. Though the composition of the amino 
acid is the same as that of the first one, it is unable 
to form amyloid-like fibrils. This suggests that the 
sequence-specific nature of a peptide is sometimes 
responsible in amyloid-like fibril formation.51
Another example of tripeptide-based amyloid 
nanofiber formation that was carried out by 
our research group includes the self-association 
of a hydrophilic tripeptide Gly-Tyr-Glu with a 
sequence identity of the N-terminal portion of an 
amyloid peptide Aβ(9–11). Upon self-assembly it 
forms amyloid-like fibrils.52 These fibrils exhibit 
significant neurotoxicity against the Neuro2 A cell 
lines. However, the other two synthetic tripeptides 
Gly-Phe-Glu, Gly-Trp-Glu, in which the Tyr 
residue at the middle position has been substituted 
by Phe or Trp, do not exhibit any amyloidogenic 
behavior and show little or no neurotoxicity.52
Eisenberg and his coworkers have studied the 
microcrystals obtained from the fibril-forming 
oligopeptide segments of a prion protein Sup35 
from yeast and the X-ray microcrystallographic 
study reveals the formation of cross-β spine 
structures at atomic resolution.53 They have also 
reported the crystal structure of 13 other segments 
obtained from amyloid-like fibril-forming 
different proteins including segments from 
Alzheimer’s amyloid-β and tau proteins, the PrP 
prion protein, insulin, islet amyloid polypeptide 
(IAPP), lysozyme, myoglobin, α-synuclein and 
β
2
-microglobulin. This study indicates that all 
these segments obtained from different amyloid 
fibril-forming peptides share a common structural 
feature (cross-β spine structure) at the molecular 
level.
Nuttall and his coworkers have studied a crystal 
structure of the amyloidogenic segment of the Aβ 
peptide (spanning the residues 18–41) with a single 
variable domain antibody Ig new antigen receptor 
(IgNAR).54 Their structural study correlates with 
the observable feature of non-fibrillar, small Aβ 
oligomers. This study also provides a model system 
for the formation of non-fibrillar oligomers in 
Alzheimer’s disease.
Jelinek and his coworkers studied the self-
aggregation property of a native penta-peptide 
fragment derived from the amyloidogenic human 
calcitonin sequence.55 They have demonstrated 
that substitutions within the sequence of native 
penta-peptide can remarkably regulate the 
kinetics of peptide self-association, and the charge 
of β-sheet organization as well as modify fibrillar 
morphology.55 Their results have also revealed that 
hydrophobic or aromatic-aromatic interactions 
are not absolutely necessary for the formation of 
peptide fibers.
Nilsson and his coworkers have demonstrated 
the role of hydrophobic, charge and steric effects on 
the self-association of a fragment of the amyloid Aβ 
peptide. Their study suggests that the amyloid fibril-
forming potential depends on the collective influence 
of aromatic, hydrophobic and steric factors.56 
In another study, they have shown that the self-
aggregation behaviour of the amyloid fragments of 
Aβ peptides is influenced by a secondary structure-
forming propensity, hydrophobicity, charge of the 
amino acid residue and steric factors.57
6.  Short Peptide-Based Nanofibrous Gels 
and Applications
Many peptide-based molecules do self-assemble 
in water to form supramolecular hydrogels. At 
the microscopic level, the morphologies of these 
supramolecular gels have been investigated by 
using conventional imaging techniques including 
SEM, TEM, and AFM. It has been found that 
most of these gels have a nanofibrillar network 
structure.58–61
In this review, we mainly discuss the short 
self-assembling water-soluble peptides, which can 
form supramolecular hydrogels under appropriate 
conditions.58–68
Ventura and his co-workers have reported 
that a dipeptide, Ile–Phe, can form hydrogel at 
1.5 wt% at pH 5.8.62 They showed that the gel is 
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transparent, and thermoreversible and forms a 
network of fibrillar nanostructures that exhibit 
strong birefringence upon Congo red binding.62 
The self-assembly of an α,β-dehydrophenylalanine 
residue (∆Phe) containing dipeptide H-Phe-
∆Phe-OH, forms a hydrogel at a concentration as 
low as 0.2 wt% in a buffer solution.63 The authors 
have investigated the ultrastructure of the gel using 
TEM and it was observed that the gel matrix is 
composed of a highly dense network of nanofibers, 
each of which is 15–20 nm in diameter and has a 
length in micrometers.63 The gel matrix has been in 
use for the encapsulation and sustained release of 
several bioactive molecules including vitamins like 
ascorbic acid, riboflavin, and vitamin B
12
, antibiotics 
like ampicillin, and antituberculosis drugs like 
L-cycloserine and isoniazid. This hydrogel does 
not exhibit any observable cytotoxicity towards 
the HeLa and L929 cell lines.
Chauhan and his coworkers have reported the 
3D growth of mammalian cells (HeLa and L929) 
on a chemically functionalized dipeptide-based 
hydrogel system.64 The dipeptide (Phe-∆Phe) based 
hydrogel has been functionalized with an “RGD” 
containing pentapeptide to facilitate the growth 
of cells and their proliferation. This functionalized 
hydrogel provided a wonderful support for 3D cell 
growth for more than two weeks and showed the 
viability of the cells, their spread and growth. This 
study provides an excellent example of a simple 
peptide based-hydrogel to attain increased cell 
growth, and promoting properties, with its high 
enzymatic stability. This gel-based soft material acts 
as a convenient template for 3D cell growth with a 
probable use in tissue engineering and cell biology.
The self-assembly of a pentapeptide fragment 
of the amyloid β-peptide NH
2
-KLVFF-COOH 
has produced a hydrogel in a phosphate-buffered 
saline (PBS) solution.65 It is expected that the 
screening of the electrostatic charges of the gel-
forming peptide enables β-sheets to self-associate 
to form a nanofibrillar gel network.65
Two self-assembled oligopeptides, namely, H
2
 
N-Gly-Ala-Ile-Leu-COOH (peptide 3) and H
2
 
N-Gly-Phe-Ile-Leu-COOH (peptide 4), can form 
hydrogels at physiological pH.66 These hydrogels 
are pH-responsive and thermoreversible. Different 
microscopy, including field emission scanning 
electron microscopy (FE-SEM), transmission 
electron microscopy (TEM), and atomic force 
microscopy (AFM) clearly reveal the presence 
of a long interconnected nanofibrillar network 
structure in the gel phase.66 Fourier transform 
infrared spectroscopy, circular dichroism and 
wide angle X-ray diffraction studies support an 
antiparallel β-sheet conformation of these gelator 
peptides in the gel phase. From these observations, 
a tentative model (Figure 2) has been proposed 
representing the formation of the gel fibers from 
the gelator peptide 4.66 The authors have used these 
hydrogels for the entrapment and slow release of 
an anticancer drug doxorubicin at physiological 
pH, promising their future applications as drug 
delivery vehicles.66 These hydrogels can entrap 
8.62 × 10−3 (M) and 13.79 × 10−3 (M) drug 
solutions (for hydrogels obtained from peptide 3 
and 4 respectively) at their respective minimum 
gelation concentrations. It has observed from the 
drug release curve that almost 85% (for the gel of 
peptide 3) and 90% (for the gel of peptide 4) of 
the drug molecules have been diffused from the 
respective gel matrix after 45 h. The authors have 
also calculated the diffusion coefficients from the 
release curve and these are 2.078 × 10−10 m2 s−1 
for the hydrogel obtained from peptide 3 and 
2.737 × 10−10 m2 s−1 for the hydrogel obtained from 
peptide 4.
Adams and his co-workers have reported the 
formation of nanofibrillar network structures 
obtained from self-assembling α-helical linear 
peptide-based gels.69 There are several examples of 
aromatic residue-containing short peptide-based 
hydrogels and these gels provide nanofibrillar 
network structures upon electron microscopic 
examination. Peptides with various hydrophobic 
conjugates including aromatic moieties like 
fluorenylmethoxycarbonyl (Fmoc),70−81 naphtha-
lene,82−88 and pyrene89,90 can provide good oppor-
tunities to be assembled in water using the π-π 
stacking interaction and hydrophobic interaction 
to form a nanofibrillar hydrogel network.
Xu and his coworkers have reported enzymatic 
intracellular hydro-gelation inside a bacterium 
(E. coli).91 An enzyme (phosphatase) was over-
expressed in E. coli and this was observed to 
trigger the formation of a hydrogelator within 
the bacterium (Figure 3). This hydrogelation 
inside the cell was found to inhibit the growth of 
the bacterium.91 This strategy, enzyme-assisted 
intracellular self-association of peptided-based 
molecules for making artificial nanostructures and 
thus regulating the fortunes of cells can give rise 
to a new method to manage the cellular process, 
comprehend cellular function and develop new 
therapeutic agents at the supramolecular level.
Bing Xu and his coworkers have demonstrated 
that tripeptide derivatives conjugated with olsalazine 
(a clinically used anti-inflammatory prodrug) 
exhibit excellent self-assembling properties in 
water to form prodrug-containing supramolecular 
hydrogels.92 They have also shown that the reduction 
of the azo group can disrupt the supramolecular 
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hydrogels and this results in the controlled release 
of an anti-inflammatory agent 5-aminosalicylic 
acid. This method may be useful for developing new 
nanobiomaterials to develop drugs at specific sites.
Self-assembling peptides and peptide derivatives 
that form nanofibrillar gels have attracted 
considerable interest as extracellular matrices 
for various applications in 3D cell culture, tissue 
engineering and regenerative medicine. There 
are several examples of nanofibrous hydrogels 
as an extracellular matrix for the growth of cells. 
Ulijn and his coworkers have reported a peptide-
based bioactive hydrogel using the molecular self-
assembly of a mixture of two aromatic short peptide 
derivatives: Fmoc-FF (Fluorenylmethoxycarbonyl-
diphenylalanine) and Fmoc-RGD (arginine-glycine-
aspartate).93 This biomimetic nanofibrous hydrogel 
acts as a 3D-scaffold for anchorage-dependent cells. 
Yang and his coworkers have developed a hydrogel 
from a collagen mimic peptide sequence.94 They 
have shown that this hydrogel has been considered 
a promising and interesting biomaterial to maintain 
and to differentiate embryonic stem (ES) cells. This 
study holds the future promise of using stem cells 
containing molecular hydrogel in regenerative 
medicine. In another study, it has been found that 
hydrogels can be obtained from the N-terminally 
protected peptide sequence Nap-FFGRGD.95 This 
hydrogel has been used for surface coating to 
functionalize poly(3-caprolactone) (PCL) films, 
and to promote cell attachment and growth. The 
potential applications of nanofibrillar peptide 
gels for biomedical uses have also been reported. 
Fibril-forming peptide gels were combined with 
cardiomyocytes or non-differentiated stem cells and 
this mixture was injected into damaged heart tissues 
for the improvement of transplanted cell survival 
and wound healing after a myocardial infarction.96,97 
Figure 2: A tentative model representing the molecular arrangement of the self-associating peptide 4 in the gel phase.66
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However, caution should be exercised in employing 
these nanofibrillar biomaterials for in vivo 
applications. This is because of some factors that can 
impact their immunogenecity and the interaction of 
these fibrils with inflammatory cells. There are a few 
reports on the examination of the immunogenecity 
of peptide-based fibrillar hydrogels. 98–101
7. Peptide Amphiphile Based Nanofibers
Interestingly, β-sheet-forming peptides have an 
extraordinary ability to form one-dimensional 
nanostructures using intermolecular hydrogen 
bonding. Further, interactions among the one 
dimensional nanostructures obtained from 
these peptides give rise to the production of a 
three-dimensional network structure. Stupp and 
his coworkers have developed a broad range of 
synthetic peptide-based amphiphilic molecules, 
which upon self-assembly form nanofibers.102–
106 These peptide-amphiphiles have a short 
hydrophobic segment, in most cases, an alkyl chain, 
attached to the N or C-terminus of an oligopeptide 
sequence with one or more hydrophilic residues. 
These peptide-amphiphiles generally self-assemble 
to form high-aspect-ratio nanofibers under specific 
solution conditions such as a particular pH, ionic 
strength of the medium and temperature.
Stupp and his coworkers also demonstrated 
that magnetic resonance (MR) agent conjugated 
peptide amphiphile based nanofibers can be 
imaged by the MRI technique, a very powerful 
diagnostic tool in clinical radiology, which provides 
three-dimensional structures of live tissues.107
The peptide-amphiphile (PA) modified 
scaffold has been used to increase the attachment 
of primary human bladder cells, and this study 
shows the potential biological application of PAs 
for the functionalization of polymeric materials 
conventionally used for tissue engineering to 
augment their bioactivity.108 Another wonderful 
application of PA-based nanofibers includes 
the adhesion of neural cells, and the migration 
and outgrowth of neurites in vitro.109 Moreover, 
these PA-based nanofibers exhibited extremely 
promising results in an animal model based on a 
spinal cord injury model of a mouse.110 All these 
results encourage the use of these peptide-based 
biomaterials in regenerative medicine.2
8. Peptide-Based Nanoporous Materials
Solely inorganic materials like zeolites and 
metal–organic frameworks consisting of both 
organic and inorganic counterparts have been 
extensively examined due to the various applications 
of these porous materials in gas storage, molecular 
separation, chiral recognition, catalysis, ion 
exchange, and in sensors.111–115 However, short peptide-
based porous materials are a new entry in this family 
of nanoporous materials. Peptide-based nanoporous 
materials possess an interesting type of biomaterial. 
Görbitz has seminal contributions in short peptide-
based nanoporous structures. Görbitz’s dipeptides, 
Val-Ala and Phe-Phe class structures formed from 
hydrophobic dipeptides,22–24,116–118 and Ripmeester’s 
dipeptide-based porous materials can adsorb inert 
gases, such as Xe.119–122
The removal of poisonous gases and energy 
demands are important issues in today’s world. 
Therefore, the absorption of poisonous gases 
including carbondioxide, and methane using 
porous materials are beneficial to the environment. 
Recently, Sozzani and his co-workers have 
demonstrated that each of the four crystalline 
dipeptides namely, Ala-Val, Val-Ala, Ile-Val 
and Val-Ile self-assemble to form nanoporous 
materials.123 They have examined their adsorption, 
separation, and storage of various gases such as 
methane, carbon dioxide, and hydrogen.123
Figure 3: A schematic representation of intracellular nanofiber formation 
leading to hydrogelation and the inhibition of bacterial growth. Adapted with 
permission from ref 91. Copyright 2007 Wiley-VCH.
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diffusing into bacteria(1)
(2)
(3)
hydrogelator
enzyme
plasmid
    IPTG
nanofiber
intrabacterial enzymatic
cleavage
intrabacterial self-assembly &
bacterial inhibition
Amphiphile:  Amphiphile 
is a chemical compound 
containing both hydrophilic 
(polar, water-loving) and 
hydropobic (nonpolar,  
water-hating) properties.
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Recently, dipeptide-based nanoporous materials 
have also been reported by our research group.7 A new 
type of dipeptide-based nanoporous material has been 
obtained from two water-soluble synthetic dipeptides 
namely β-alanyl-L-phenylglycine (peptide 5) and 
L-phenylglycyl-β-alanine (peptide 6). N
2
 gas 
adsorption and desorption studies have been 
performed using these peptide-based nanoporous 
materials. The adsorption capacity has been found to 
be of 173 ccg−1 and 71 ccg−1 and BET surface area of 
56.76 m2 g−1 and 41.73 m2 g−1 for these two peptides, 
respectively. Görbitz’s porous materials obtained 
from hydrophobic dipeptides are based fully on 
α-amino acids and they have pore diameters ranging 
from 3–10 Å.22,23,116 However, our reported dipeptide-
based porous materials are composed of a hybrid of 
a and β-amino acids, with different pore sizes.7 These 
pore sizes vary from 6.4 to 3.2 Å. Interestingly, these 
nanoporous materials obtained from dipeptides 
have been observed to be biodegradable towards the 
soil bacterial consortium. This suggests that these 
short peptide based nanoporous materials are eco-
friendly. An example of porous materials based on 
cyclic peptide building blocks has also been reported 
by our research group.124
9.  Peptide-Based Vesicles and their 
Applications
Vesicles seem to be enclosed spherical structures 
having the capacity to encapsulate various materials. 
The entrapped materials can be released by 
rupturing these vesicles under suitable conditions. 
Vesicles offer interesting functions including 
chemical-sensing/bio-sensing, encapsulation and 
sustained release of drugs and other biologically 
important molecules.125 A report of Gazit and 
his coworkers includes diphenylglycine and 
diphenylalanine-based hollow nanospheres which 
exhibit significant stability.126 Nanovesicles can also 
be obtained from self-assembling dipeptides α,β-
dihydrophenylalanine residues (∆Phe).127 These 
vesicles can encapsulate small drug molecules 
and other biologically important molecules such 
as riboflavin, vitamin B
12
, bioactive peptides and 
even a protein. These vesicles are resistant towards 
the proteolytic enzyme, proteinase K.127
A very recent report by our research group 
includes the development of nontoxic multivesicular 
structures from self-assembling water-soluble 
dipeptides containing glutamic acid residues at the 
C terminus.125 These vesicles are stable over a wide 
range of pH (pH 2–12). However, these vesicles are 
responsive towards calcium ions. Interestingly, the 
encapsulation of the anticancer drug doxorubicin 
and its release in the presence of calcium ions has 
been observed. Furthermore, these vesicles can be 
used as carriers for biologically important molecules, 
such as cyclic adenosine monophosphate (cAMP) 
within the cells, while their biological functions 
remains unchanged. So, these peptide vesicles may 
be used as biocompatible drug delivery vehicles.125
10.  Morphological Nanostructural 
Transformations
The transformation of one nanoscopic species 
to an other nanoscopic species is an interesting 
phenomenon. This transition from one 
nanostructure to another type of nanostructure 
e.g., nanotubes to nanovesicles can be either stimuli 
responsive or due to a slight change in the molecular 
structure. Precise control over the morphology of the 
nanostructure is a challenging task. Some molecular 
building blocks, upon self-assembly in a particular 
condition, can give rise to a particular nanoscale 
structure. The pattern or mode of assembly can 
be manipulated by the proper selection of pH, 
solute concentration, salt concentration or even by 
changing the solvent system.
A dipeptide (D-Phe-D-Phe) has been self-
assembled in water to form a nanotubular 
structure with diameters ranging from 2 nm to 
100 mm. Interestingly, vesicles have been observed 
in addition to the nanotubes, when this nanotube 
solution was diluted with an appropriate volume 
of water. This observation suggests that the 
concentration of the peptide plays a key role in 
determining the construction either of nanotubes 
only or of a mixture of nanotubes and nanovesicles.128 
An example of nanotube to nanovesicle conversion 
has been recently reported by Junbai Li and his 
co-workers. They have demonstrated that a cationic 
dipeptide (H-Phe-Phe-NH
2 
·
 
HCl) derived from 
Phe-Phe can be self-assembled into nanotubes at 
physiological pH. A spontaneous conversion from 
nanotubes to spherical vesicle-like structures occurs 
and it has been observed with the dilution of the 
peptide scaffold.129,130
Another fascinating example of nanovesicle to 
nanotube transformation observed by our research 
group includes the concentration dependent 
transformation of nanovesicles to nanotubes of an 
oligopeptide, Acp-Tyr-Glu (Acp, ε-amino caproic 
acid) at neutral pH.6 This peptide self-assembles to 
form nanovesicles at a concentration of 6.9 mgmL−1, 
whereas nanotubular structures have been observed 
at a concentration of 2.3 mgmL−1. An ordered 
array of fused vesicular structures was formed at 
an intermediate concentration of 3.4 mgmL−1 and 
this type of fused vesicular structure promotes the 
formation of a nanotubular structure upon dilution. 
In this study, the concentration of the peptide plays 
a vital role in dictating what type of nanostructure 
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can be formed: nanovesicles or nanotubes or fused 
vesicular structures (Figure 4). CD and FTIR data of 
the tripeptide Acp-Tyr-Glu suggest that the peptide 
adopts a turn-like structure in solution at neutral 
pH and this turn like structure is independent of 
dilution. A curved self-assembled structure can be 
formed from the self-association of the turn-like 
structure. A vesicular structure can be obtained by 
the two-dimensional layer closure of this curved 
supramolecular structure. The rolling up of this 
curved structure in one direction leads to the 
formation of a nanotubular structure (Figure 5). 
These vesicular structures are responsive towards 
biocompatible Ca2+ ions and pH of the solution.6 The 
presence of calcium ions or high pH (10.7) triggers 
the breaking of these nanovesicles. These nanovesicles 
can entrap a potent anticancer drug doxorubicin 
and the drug can also be released in the presence of 
calcium ions. This holds out the promise of applying 
these nanovesicles as nanovehicles to carry drug and 
other biologically important molecules.
A report by our research group includes the 
pH-responsive nanostructural transition of a self-
assembling tripeptide Tyr-Aib-Ala (Aib: α-amino 
isobutyric acid) from nanotubes to nanovesicles.131 
At acidic pH, a hollow tubular structure at nanoscale 
measurements has been observed. However, 
the uniform coexistence of both nanotubes and 
nanovesicles has been observed at pH 6.5. A further 
increase in pH leads to the formation of only one 
nanoscopic structure (nanovesicle) exclusively and 
these vesicles are stable in the pH range 7.0–9.2. The 
rupturing of these nanovesicles has been observed 
at a higher pH (pH >9.2). The entrapment and 
sustained release of a physiological dye, Congo 
red, has been performed using the pH-sensitivity 
of these nanovesicles.131
An interesting example of peptide–dendron 
hybrid-based nanostructural tranformation from 
nanotubes to nanofibrillar aggregates has been 
reported by Parquette and his coworkers. This 
transformation can be carried out either by changing 
the pH or altering the salt concentration (NaCl).132 
Only nanotubular structures have been observed 
at a lower pH (pH 1) and at a higher pH (pH 11) 
since, as the lysine side chains are deprotonated, 
a nanofibrillar structure is obtained. At lower 
salt concentrations (50 mM NaCl) a mixture of 
nanotubes and nanofibrillar structures have been 
found, while at higher concentrations of salt (100–
200 mM), only nanofibrils have been obtained.132
The pH-triggered change in the morphology of a 
surfactant-like octapeptide, Ac-IIEENNDD-OH has 
been observed in aqueous solution. Twisted ribbons 
have been found at a pH less than 4. However, 
nanospheres have been obtained above pH 4.133 
Another example of pH-dependent nanostructural 
transformation includes the transition in a 
tryptophane zipper-forming peptide-based molecule, 
from nanospheres to a mixture of nanospheres and 
nanofibers.134 A solvent-dependent morphological 
transformation from a hollow nanosphere to a 
Figure 4: A pictorial representation of the concentration dependent 
nanostructural transition from nanovesicles to nanotubes via an intermediate 
nanostructure, an ordered array of fused nanovesicles: (i) nanovesicles, (ii) an 
intermediate, well-defined array of fused nanovesicles, (iii) a nanotube.6
Figure 5: A tentative model for the formation of 
a nanotube and a nanovesicle from (a) turn-shaped 
molecular conformation, (b) molecular assembly 
with a curvature, (c) two dimensional layer closure 
of this curved structure gives rise to a nanovesicle, 
(d) rolling of this curved structure in one direction 
leads to the formation a nanotube.6
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nanofiber in a peptide based soft self-assembly has 
been reported by Verma and his coworkers.135
Ihee and his coworkers have demonstrated 
an interesting morphological transformation 
between nanowires and nanotubes based on the 
self-assembly of diphenylalanine.136 Nanotubes 
have been obtained by dissolving the peptide in 
water by sonication followed by heating, whereas 
nanowires have been obtained in water at high 
ionic strength. These two morphologies can be 
interconverted.136 Nanotubular morphologies 
can be obtained by sonication and heating of the 
dispersed nanowires in water. On the other hand, 
nanowire morphologies have been obtained by 
dissolving the dried nanotubes in TFA and later 
titrating the solution with NH
4
OH.136
So far, the morphological transformation 
from one nanostructure to another nanostructure 
has been discussed, where the basic peptide-
based building blocks are unchanged. Depending 
on conditions such as pH, concentration, salt 
concentration and others, a nanostructural 
transition occurrs. However, by slightly varying 
the molecular structure in a self-assembling peptide 
system, nanostructural transformation has also been 
reported.126,137 Gazit and his co-workers have reported 
a dipeptide-based nanotube to hollow nanocage 
structural transition by simply attaching a thiol 
group at the terminal position of the dipeptide.126 
It is reported that diphenylalanine (Phe-Phe), 
can be self-assembled in 1,1,1,3,3,3-hexafluoro-
2-propanol to form a peptide nanotube. A slight 
change in the building block from diphenylalanine 
to diphenylglycine forms remarkably stable 
nanospheres with diameters of 10–100 nm under the 
same solution conditions.126 Lu and his coworkers 
have reported that structural transitions (sheets, 
fibers, worm-like micelles, and short rods) can be 
influenced by increasing the hydrophobic peptide 
region in a series of peptide surfactant systems.137
11. Conclusions
The making of peptide-based specific 
nanostructures (e.g., nanotubes or nanovesicles) 
using controlled self-assembly under appropriate 
conditions still remains a challenging task. This is 
due to the fact that nanostructural transformation 
from one nanoscopic structure to an other 
sometimes occurs, or a mixture of nanostructures 
(like nanotubes and nanovesicles) can be obtained 
in the process of preparing a specific nanostructure 
with desired dimensions in an aqueous solution. 
So, the proper choice of peptide based building 
blocks is not the only determining factor for a 
specific type of nanostructure; the appropriate 
conditions (concentration, pH, solvent and 
others) can also play a vital role in determining a 
particular type of self-assembling pattern which 
can give rise to a specific type of nanostructure 
(e.g., a nanotube or a nanovesicle or a mixture of 
both). Vesicles and nanofibrillar gels are attractive 
targets for making nanobiomaterials drug delivery 
vehicles. The proper selection of peptide-based 
molecular building blocks and the tuning of 
the self-assembling pattern under appropriate 
conditions still remains a challenging issue in 
making the desired peptide-based vesicular or 
fibrous gel-based nanobiomaterials that can carry 
some bioactive molecules as cargo to the targeted 
site. So, it is important to make vesicular assemblies 
or nanofibrous gels with a peptide sequence 
that can be targeted towards a specific location 
inside the cell. The peptide-based porous materials 
can be biodegradable compared to conventional 
porous materials. Controlling the porosity of self-
assembling peptide-based nanoporous material is 
also challenging. It is necessary to obtain a short 
peptide-based porous material with a well-defined 
nanoscale dimension and to modulate its porosity, so 
that the porous material with a smaller pore size can 
only adsorp gases with a small molecular dimension 
(e.g., H
2
) from a mixture of gases selectively.
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